Manuel Barreiro-De-Acosta

56PUBLICATIONS
347CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)SurgeryDisease surveillanceItalian language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 12, 2026
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

|Aug 02, 2026
Editorial: Risankizumab in Refractory Crohn's Disease-From Real-World Effectiveness to Strategic Positioning and Early Monitoring. Authors' Reply.

|Jul 07, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

|Jul 01, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

|Jun 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

|May 15, 2026
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United States.

Pageof 10

Frequent Collaborators

25 joint publications

Javier Pérez Gisbert

18 joint publications

María Chaparro

17 joint publications

Iago Rodríguez-Lago

14 joint publications

Francisco Mesonero Gismero